StockData
cbdMD, Inc. logo

cbdMD, Inc. (YCBD) company profile

YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.36+0.00 (+0.28%)

Close on Nov 17, 2026Market cap $4.08MP/E –Yield –

About cbdMD

Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844

cbdMD, Inc. develops, manufactures, and markets natural wellness supplements and functional consumer products. The business offers broad-spectrum and full-spectrum hemp-derived cannabinoid items, including tinctures, gummies, capsules, and topicals under its core cbdMD label. It also provides pet supplements under Paw CBD, functional mushroom formulations through ATRX, and ready-to-drink cannabinoid beverages under the Herbal Oasis line. Its customer base includes individual consumers shopping online as well as business clients comprising regional retailers, specialty stores, and beverage wholesalers.

The enterprise is headquartered in Charlotte, North Carolina. It distributes merchandise throughout the United States via e-commerce and retail networks, with beverage availability across southeastern states such as North Carolina, Florida, Georgia, Alabama, Tennessee, and Texas. The firm sells through supermarket chains, specialty grocers, and alcohol retailers, and it reaches international markets by partnering with distributors in Central and South America.

Summary of the business section of cbdMD's latest annual report, written by StockData.

Company profile

Company

Legal name
cbdMD, Inc.
Headquarters
Charlotte, NC
Address
8845 Red Oak Boulevard 28217
Phone
(704) 445-3060
Website
cbdmd.com
Employees
42, Sep 30, 2025
Industry
Perfumes, Cosmetics & Other Toilet Preparations
Incorporated in
North Carolina
Fiscal year ends
September 30
Auditor
Cherry Bekaert LLP, Charlotte, North Carolina

Stock & identifiers

Ticker
YCBD
Exchange
NYSE
IPO date
Nov 17, 2017
Shares outstanding
11M, Aug 13, 2026
Public float
$1.64M, Mar 31, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-8 reverse, May 7, 2025; 1-for-45 reverse, Apr 25, 2023
SEC CIK
1644903
CUSIP
12482W408
ISIN
US12482W4087
FIGI
BBG00J3H4KT7
Share class FIGI
BBG00J3H4LJ6
EIN
47-3414576

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Thomas Ronan KennedyCEO and CFO, Director513,722
Scott G. StephenDirector25,464
William F. Raines IIIDirector2,293,758
Sibyl Nichole SwiftDirector4,145
Bakari T. SellersDirector4,324
Jeffrey H. PorterDirector576,674
Kevin Charles RoeDirector26,707

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026
Kevin Mac Dermott
–$300.00K$207.31K––
FY2026
Ronan Kennedy
$300.00K$300.00K$207.31K––
FY2025
Kevin Mac Dermott
–$275.01K$181.38K––
FY2025
Ronan Kennedy
$275.00K$275.01K$181.38K––
FY2024
Kevin Mac Dermott
–$384.64K$191.44K––
FY2024
Ronan Kennedy
$384.62K$384.64K$191.44K––

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusTotalvs. prior year
Ronan Kennedy
CEO and CFO
$275.00K$25.00K$300.00K+9%
Bradley Whitford
Chief Accounting Officer (2)
$192.31K$15.00K$207.31K+14%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“At December 1, 2025 we had approximately 42 full-time employees and employ additional contractors to support the organization’s efforts.”

Corporate history

Events identified from SEC filings

DateEventDetails
Nov 4, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 6, 2025DelistingNotice of delisting from exchange (Form 25)
Jan 3, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 30, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 26, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 10, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 11, 2019ListingRegistration of securities on an exchange (Form 8-A)
May 1, 2019Name changeName changed from Level Brands, Inc. to cbdMD, Inc.
Dec 20, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 15, 2017ListingRegistration of securities on an exchange (Form 8-A)
Sep 27, 2016Name changeName changed from LEVEL BEAUTY GROUP, INC. to Level Brands, Inc.

See a number that looks wrong?